Nasdaq: OCX. $2.60. + 0.01 (0.39%) Data is delayed by 15 minutes. More +. Events & Presentation. No upcoming events scheduled at this time. Investor ...
... Investor Relations · Leadership Team · Oncocyte Careers · Contact Us. Where ... Investors. Addressing unmet needs. Oncocyte is a precision diagnostics company ...
Find annual and quearterly earnings data for Oncocyte Corporation Common Stock (OCX) including earnings per share, earnings forecasts at Nasdaq.com.
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more. Before you Invest, Investor.gov. Get ...
Missing: relations | Show results with:relations
People also ask
Who is the transfer agent for Oncocyte?
What is an investor relations strategy?
Mar 28, 2024 · OncoCyte (OCX) Investor Presentation - Slideshow · SA TranscriptsWed, Dec. 02, 20201 Comment · OncoCyte Corporation (OCX) CEO Ronnie Andrews on ...
Missing: relations | Show results with:relations
Investor Relations Intelligence. Featured Solutions. Nasdaq Boardvantage® · Board Evaluations · Nasdaq IR Insight® · Nasdaq Metrio · See All Solutions ->. About.
Oncocyte Corp. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View OCX financial statements in full.
Missing: relations | Show results with:relations